Table 1.
Patient | Age (years) | Tumor type | Tumor histology/histological grade | Samples analyzed | ||
---|---|---|---|---|---|---|
Mesenchymal tumors | Endometrial sarcomas | 6 | 76.7 | Recurrent | Endometrial stromal sarcoma, low grade | T |
13 | 60.1 | Recurrent | Undifferentiated endometrial sarcoma | T | ||
16 | 43.3 | Primary | Undifferentiated endometrial sarcoma | T | ||
17 | 74.8 | Primary | Undifferentiated endometrial sarcoma | T, C | ||
31 | 51.0 | Primary | Endometrial stromal sarcoma, low grade | T, C | ||
36 | 64.6 | Primary | Undifferentiated endometrial sarcoma | T, C | ||
38 | 44.8 | Primary | Endometrial stromal sarcoma, low grade | T, C | ||
52 | 78.1 | Primary | Undifferentiated endometrial sarcoma | T | ||
62 | 53.4 | Primary | Undifferentiated endometrial sarcoma | T, C | ||
64 | 68.9 | Primary | Undifferentiated endometrial sarcoma | T | ||
Smooth muscle tumors | 2 | 52.6 | Recurrent | Leiomyosarcoma/G3 | T, C | |
12 | 56.3 | Primary | Leiomyosarcoma/G3 | T, C | ||
23 | 63.2 | Recurrent | Leiomyosarcoma/G2 | T | ||
26 | 45.8 | Recurrent | Leiomyosarcoma/G3 | T | ||
28 | 51.5 | Recurrent | Leiomyosarcoma/G2 | T | ||
35 | 57.5 | Recurrent | Leiomyosarcoma/G2 | T | ||
63 | 40.5 | Recurrent | Leiomyosarcoma/G3 | T | ||
90 | 59.1 | Recurrent | Leiomyosarcoma/G2 | T | ||
Mixed epithelial and mesenchymal tumors | 3 | 75.5 | Recurrent | Carcinosarcoma heterologousa | T | |
11 | 61.4 | Primary | Carcinosarcoma homologousb | T, C | ||
14 | 23.2 | Primary | Adenosarcoma homologous | T, C | ||
18 | 66.4 | Primary | Carcinosarcoma heterologous | T | ||
24 | 66.6 | Primary | Carcinosarcoma heterologous | T, C | ||
25 | 61.0 | Recurrent | Carcinosarcoma homologous | T | ||
30 | 64.3 | Primary | Carcinosarcoma heterologous | T, C | ||
66 | 55.1 | Primary | Carcinosarcoma homologous | T, C | ||
67 | 59.7 | Primary | Adenosarcoma homologous | T | ||
71 | 55.5 | Recurrent | Adenosarcoma homologous | T | ||
86 | 53.8 | Recurrent | Adenosarcoma homologous | T |
Abbreviations: T tumor sample, C control, i.e., a sample of normal uterine tissue obtained from the same patient
aHeterologous tumor—representing malignant counterparts that normally do not occur in the uterus
bHomologous tumor—representing malignant counterparts of tissues indigenous to the uterus